You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

Recruiting
  • Multiple Myeloma
  • ATAC-seq and ChIP-seq
  • Roma, Italy
  • +1 more
May 4, 2023

Multiple Myeloma Trial in Houston (Belumosudil mesylate)

Not yet recruiting
  • Multiple Myeloma
  • Belumosudil mesylate
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2023

Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)

Not yet recruiting
  • Multiple Myeloma
  • Bone marow biopsy and aspiration
  • biochemical and heamatological tests
  • (no location specified)
Aug 9, 2023

Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

Completed
  • Multiple Myeloma
  • Blood and bone marrow sampling
  • Rennes, France
    CHU Rennes
Feb 2, 2023

Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Plasma Cell Leukemia in Relapse
  • Biological
  • Shanghai, Shanghai, China
    Shanghai Tongji Hospital
May 29, 2023

Multiple Myeloma Trial in Nantong (Colchicine, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 25, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • VRD
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 5, 2023

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • CT0594CP
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Apr 18, 2023

MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

Not yet recruiting
  • Multiple Myeloma
  • Minimal Residual Disease
    • (no location specified)
    Nov 1, 2023

    Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

    Not yet recruiting
    • Multiple Myeloma
    • Plasma Cell Myeloma
    • Zirconium Zr 89-DFO-YS5
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    May 26, 2023

    Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

    Completed
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Relapsed or Refractory Multiple Myeloma
    • BEBT-908 for injection
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Oct 9, 2023

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Solid Tumors, Adult, Multiple Myeloma, Lymphoma Trial in San Antonio (VP301)

    Recruiting
    • Solid Tumors, Adult
    • +2 more
    • San Antonio, Texas
      NEXT Oncology
    Jan 16, 2023

    Multiple Myeloma Trial (Linvoseltamab)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Apr 12, 2023

    Relapsed or Refractory Multiple Myeloma Trial (Cevostamab, Elranatamab, Tocilizumab)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Jun 22, 2023

    Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Detroit, Michigan
    • +1 more
    Jan 27, 2023

    Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

    Recruiting
    • Multiple Myeloma in Relapse
    • Aurora, Colorado
      University of Colorado Hospital
    Jan 31, 2023

    Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

    Recruiting
    • Multiple Myeloma
    • Circadian Effective Lighting
    • Circadian Ineffective Lightning (CIL)
    • New York, New York
    • +1 more
    Feb 10, 2023

    Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

    Not yet recruiting
    • Multiple Myeloma
    • Boston, Massachusetts
    • +1 more
    Nov 2, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)

    Active, not recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Poitiers, France
      CHU Poitiers
    Jan 9, 2023

    Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

    Recruiting
    • Breast Cancer
    • +4 more
    • Web bases survey
    • Canton, Ohio
      Cleveland Clinic Mercy Hospital
    Aug 2, 2023

    Based on PRO Data Reported ThroughMHealth App Solution in

    Completed
    • Multiple Myeloma
    • mHealth app
    • Odense, Denmark
      Odense University Hospital
    Feb 10, 2023